The Valley Desk

NCT01592370 · Interventional trial

An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

Overall registry status Completed

Phase 1 · Phase 2

Conditions Hodgkin Lymphoma, Multiple Myeloma, Non-Hodgkin's Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov